Objective: There are a limited number of studies on the seroprevalence of Hepatitis B virus (HBV) and Hepatitis C virus (HCV) infection in Turkey. This study aimed to compare HBV and HCV seroprevalence rates before and after the implementation of national hepatitis B vaccination program (NHPVP) and to explore age-related changes in the seroprevalences.
Materials and Methods:Results of Hepatitis B surface antigen (HBsAg), Hepatitis B virus surface antibody (antiHBs) and anti-HCV tests performed during 2009 and 2010 in a state hospital laboratory were reviewed retrospectively. As NHPVP was started in 1998, 12 years of age and younger children were considered post-NHPVP period subjects.Results: A total of 3280 HBsAg, 2444 antiHBs and 3188 anti-HCV test results were reviewed, representing approximately 3% of the population of the city where the study was conducted. HBsAg, antiHBs and anti-HCV positivity were 3.2%, 36.12% and 0.97%, respectively. HBsAg and antiHBs positivity were higher among males (p<0.001). When assessed by age groups, HBsAg positivity was found to be the lowest in the age group 0-12 and highest in the age group 51-60. HBsAg positivity was lower in the post-NHPVP period versus pre-NHPVP period (p=0.01). Anti-HCV positivity was similar for pre-and post-NHPVP periods (p>0.05).
Conclusion:Owing to the use of NHPVP, HBsAg seropositivity has decreased, and it is expected to decrease further in the next years with a wider implementation of the program. Efforts should be continued to increase the level of awareness in the community for HBV and the importance of immunization.
Bulgular:Çalışmanın yapıldığı il nüfusunun yaklaşık %3'üne tekabül eden 3280 HBsAg, 2444 antiHBs ve 3188 anti-HCV test sonucu değerlendirmeye alındı. HBsAg, antiHBs ve anti-HCV pozitifliği sırasıyla %3,2, %36,12 ve %0,97 bulundu. HBsAg ve antiHBs pozitifliği erkeklerde kadınlardan daha yüksekti (p<0,001). Yaş gruplarına göre HBsAg pozitifliği en düşük 0-12 yaş arası, en yüksek 51-60 yaş arası bulundu. UHBAP öncesi dönemde UHBAP sonrası döneme göre HBsAg pozitifliği daha düşüktü (p=0,01). Anti-HCV pozitifliği UHBAP öncesi ve sonrası dönemde benzerdi (p>0,05).Sonuç: UHBAP ile beraber HBsAg seropozitifliği azalmış ve programın daha geniş bir şekilde uygulanmasıyla önümüzdeki yıllar-da daha da azalacağı beklenmektedir. HBV ile bağışıklamanın önemi hakkında toplumun farkındalık düzeyini artırıcı faaliyetlere devam edilmelidir.